Doris R. Siwak

2.5k citations

27 papers · 1.7k indexed · h-index 18

Molecular Medicine top 5%
Oncology top 5%
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 3
Molecular Biology top 10%
- Advanced Biosensing Techniques and Applications 4
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Kinase Regulation and GTPase Signaling 3
- Retinoids in leukemia and cellular processes 3
Cancer Research top 10%
Immunology and Allergy top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5
Spectroscopy
- Advanced Proteomics Techniques and Applications 3

Co-authors: Gordon B. Mills Bharat B. Aggarwal Shishir Shishodia Razelle Kurzrock Yiling Lu T. Christopher Windham Gary E. Gallick Justin M. Summy
Cited by: Molecular Medicine Oncology Molecular Biology
Journals: Nature Communications (1 paper)Nature Genetics (1 paper)Bioinformatics (2 papers)
Partner nations: United States Japan Canada

In The Last Decade

Doris R. Siwak

27 papers receiving 1.6k citations

Peers

Countries citing papers authored by Doris R. Siwak

Since Specialization

Citations

This map shows the geographic impact of Doris R. Siwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris R. Siwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris R. Siwak more than expected).

Fields of papers citing papers by Doris R. Siwak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris R. Siwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris R. Siwak. The network helps show where Doris R. Siwak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Doris R. Siwak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Doris R. Siwak Line = papers co-authored together Doris R. Siwak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets Nature Communications ·Masashi Fujita,Mei-Ju May Chen,Doris R. Siwak,Shota Sasagawa,Ayako Oosawa-Tatsuguchi,Koji Arihiro,Atsushi Ono,Ryoichi Miura,Kazuhiro Maejima,Hiroshi Aikata,Masaki Ueno,Shinya Hayami,Hiroki Yamaue,Kazuaki Chayama,Ju‐Seog Lee,Yiling Lu,Gordon B. Mills,Han Liang,Satoshi Nishizuka,Hidewaki Nakagawa	2022	13
2	Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling British Journal of Cancer ·Mizunori Yaegashi,Takeshi Iwaya,Noriyuki Sasaki,Masashi Fujita,Zhenlin Ju,Doris R. Siwak,Tsuyoshi Hachiya,Kei Sato,Fumitaka Endo,Toshimoto Kimura,Koki Otsuka,Ryo Sugimoto,Tamotsu Sugai,Lance A. Liotta,Yiling Lu,Gordon B. Mills,Hidewaki Nakagawa,Satoshi Nishizuka	2021	7
3	Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA PLoS ONE ·Noriyuki Sasaki,Takeshi Iwaya,Takehiro Chiba,Masashi Fujita,Zhenlin Ju,Fumitaka Endo,Mizunori Yaegashi,Tsuyoshi Hachiya,Ryo Sugimoto,Tamotsu Sugai,Doris R. Siwak,Lance A. Liotta,Yiling Lu,Gordon B. Mills,Hidewaki Nakagawa,Satoshi Nishizuka	2020	4
4	Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies Advances in experimental medicine and biology ·Doris R. Siwak,Jun Li,Rehan Akbani,Han Liang,Yiling Lu	2019	12
5	GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity Oncogene ·Gordana Marić,Matthew G. Annis,Patricia MacDonald,Caterina Russo,Dru Perkins,Doris R. Siwak,Gordon B. Mills,Peter M. Siegel	2019	36
6	Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells Molecular Cancer Therapeutics ·Ping Fan,Doris R. Siwak,Balkees Abderrahman,Fadeke A. Agboke,Smitha Yerrum,V. Craig Jordan	2019	20
7	LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer Cancer & Metabolism ·Fanny Dupuy,Takla Griss,Julianna Blagih,Gaëlle Bridon,Daina Avizonis,Ling Chen,Zhifeng Dong,Doris R. Siwak,Matthew G. Annis,Gordon B. Mills,William J. Muller,Peter M. Siegel,Russell G. Jones	2013	39
8	Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia PLoS ONE ·Mary E. Irwin,Laura D. Nelson,Janice M. Santiago‐O’Farrill,Phillip Knouse,Claudia P. Miller,Shana L. Palla,Doris R. Siwak,Gordon B. Mills,Zeev Estrov,Shulin Li,Steven M. Kornblau,Dennis P.M. Hughes,Joya Chandra	2013	18
9	Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Sarah Wheeler,Doris R. Siwak,Raymond L. Chai,Courtney R. LaValle,Raja R. Seethala,Lin Wang,Kathleen Cieply,Carol Sherer,Corwin Joy,Gordon B. Mills,Athanassios Argiris,Jill M. Siegfried,Jennifer R. Grandis,Ann Marie Egloff	2012	63
10	Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity Cancer Research ·Dessislava A. Nikolova,Irfan A. Asangani,Laura D. Nelson,Dennis P.M. Hughes,Doris R. Siwak,Gordon B. Mills,A. Harms,Erika Buchholz,Lothar R. Pilz,Christian Manegold,Heike Allgayer	2009	23
11	Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19‐9 levels in pancreatic cancer PROTEOMICS ·Tobias Grote,Doris R. Siwak,Herbert A. Fritsche,Corwin Joy,Gordon B. Mills,Diane M. Simeone,David C. Whitcomb,Craig D. Logsdon	2008	66
12	A module of negative feedback regulators defines growth factor signaling Nature Genetics ·Ido Amit,Ami Citri,Tal Shay,Yiling Lu,Menachem Katz,Fan Zhang,Gabi Tarcic,Doris R. Siwak,John Lahad,Jasmine Jacob‐Hirsch,Ninette Amariglio,Nora Vaisman,Eran Segal,Gideon Rechavi,Uri Alon,Gordon B. Mills,Eytan Domany,Yosef Yarden	2007	360
13	Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells The FASEB Journal ·Hiroshi Aoki,Eiji Iwado,Mark S. Eller,Yasuko Kondo,Keishi Fujiwara,Guang‐Zhi Li,Kenneth R. Hess,Doris R. Siwak,Raymond Sawaya,Gordon B. Mills,Barbara A. Gilchrest,Seiji Kondo	2007	58
14	Identification of selective inhibition of phospho-S6 ribosomal protein in XK469 sensitive leukemia cell lines using functional proteomic analysis Cancer Research ·Raoul Tibes,Yiling Lu,Doris R. Siwak,Bryan T. Hennessy,Ruth LaPushin,Gordon B. Mills	2005	2
15	Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway Cancer ·Doris R. Siwak,Shishir Shishodia,Bharat B. Aggarwal,Razelle Kurzrock	2005	192
16	The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells Oncology Reports ·Edgar Mendoza-Gamboa,Doris R. Siwak,Ana M. Tari	2004	7
17	KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2 Clinical & Experimental Metastasis ·Xiaoping Zang,Doris R. Siwak,Thi X. Nguyen,Ana M. Tari,J. Thomas Pento	2004	21
18	Liposomal Antisense Oligonucleotides for Cancer Therapy Methods in enzymology on CD-ROM/Methods in enzymology ·Doris R. Siwak,Ana M. Tari,Gabriel Lopez‐Berestein	2004	5
19	The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002. PubMed ·Doris R. Siwak,Ana M. Tari,Gabriel Lopez‐Berestein	2002	37
20	Src activation regulates anoikis in human colon tumor cell lines Oncogene ·T. Christopher Windham,Nila U. Parikh,Doris R. Siwak,Justin M. Summy,David J. McConkey,Alan J. Kraker,Gary E. Gallick	2002	173

About Doris R. Siwak

Doris R. Siwak is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Advanced Biosensing Techniques and Applications (4 papers), Advanced Proteomics Techniques and Applications (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Peptidase Inhibition and Analysis (3 papers), Retinoids in leukemia and cellular processes (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Molecular Medicine (114 citations), Oncology (462 citations) and Molecular Biology (1.2k citations). Doris R. Siwak has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Gordon B. Mills, Bharat B. Aggarwal, Shishir Shishodia, Razelle Kurzrock, Yiling Lu, T. Christopher Windham, Gary E. Gallick, Justin M. Summy, Alan J. Kraker and David J. McConkey. Their work appears in journals such as Nature Communications, Nature Genetics and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact